 |
 |

Acquired Hemolytic Anemia in Chronic Lymphocytic Leukemia and the LymphomasSurvival and Response to Therapy in Twenty-Seven Cases
ROBERT A. KYLE, M.D.;
JOSEPH M. KIELY, M.D.;
J. M. STICKNEY, M.D.
AMA Arch Intern Med. 1959;104(1):61-67.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
The presence of severe anemia in patients with chronic lymphocytic leukemia or malignant lymphoma is regarded ordinarily as a bad prognostic sign, often indicating advanced disease or extensive involvement of bone marrow. In some patients, however, marked anemia is due to an overt hemolytic process, and recognition of this fact will lead to proper therapy and a more favorable prognosis.
In 1906, Pappenheim 1 stated that the anemia in lymphocytic leukemia was chiefly myelophthisic in nature but that it was possible in some instances for the anemia to be of hemolytic origin and caused by toxic hemolyzing substances from the tumor tissue. The first report of acquired hemolytic anemia associated with chronic lymphocytic leukemia was given by Paschkis,2 in 1927. That same year Holler and Paschkis 3 presented the first report of Hodgkin's disease complicated by acquired hemolytic anemia. Since then other cases of Hodgkin's disease, lymphosarcoma, and chronic
. . . [Full Text PDF of this Article]
Author Affiliations
Rochester, Minn.
Fellow in Medicine, Mayo Foundation (Dr. Kyle) and Section of Medicine (Dr. Kiely and Dr. Stickney), Mayo Clinic and Mayo Foundation. The Mayo Foundation, Rochester, Minn., is a part of the Graduate School of the University of Minnesota.
Footnotes
Submitted for publication Oct. 9, 1958.
Abridgment of thesis submitted by Dr. Kyle to the Faculty of the Graduate School of the University of Minnesota in partial fulfillment of the requirements for the degree of Master of Science in Medicine.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|